Skip to main content
Fig. 2 | Critical Care

Fig. 2

From: Anticoagulation options for continuous renal replacement therapy in critically ill patients: a systematic review and network meta-analysis of randomized controlled trials

Fig. 2

Network geometry of all the included anticoagulation options for evaluating filter lifespan. The size of the nodes and the thickness of the lines were proportional to the sample size and number of direct comparisons, respectively. Lines do not connect nodes when there were no head-to-head trials between two treatments. Abbreviations: UFH: unfractionated heparin; RCA: regional citrate anticoagulation; LMWH: low-molecular-weight heparin; PGI2: prostaglandin I2; NM: nafamostat mesilate; and No: no anticoagulation

Back to article page